stock
CRSP · CRISPR Therapeutics AG
What CRISPR Therapeutics AG reports to the SEC, read from its filings.
Open in the appPrice
The live CRSP price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CRSP.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 96,692,653 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -3990.0%
- Net
- -3368.7%
Returns
- ROE
- -25.8%
- ROA
- -17.0%
Health
- Current ratio
- 17.8x
- Debt/equity
- 0.3x
Deep value
- NCAV
- $1.47B
- NCAV per share
- $15.18
- Price/NCAV
- Locked
- NNWC
- -$612.88M
- NNWC per share
- -$6.34
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $10.18M | —Gross profit: unreported by this company. | -$117.27M | -$91.15M | 10-Q filed 2026-08-03 |
| 2026-03-31 | $1.46M | —Gross profit: unreported by this company. | -$130.25M | -$122.93M | 10-Q filed 2026-08-03 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $864,000 | —Gross profit: unreported by this company. | -$154.76M | -$130.61M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $889,000 | —Gross profit: unreported by this company. | -$132.06M | -$106.44M | 10-Q filed 2025-11-10 |
| 2025-06-30 | $892,000 | —Gross profit: unreported by this company. | -$229.32M | -$208.55M | 10-Q filed 2026-08-03 |
| 2025-03-31 | $865,000 | —Gross profit: unreported by this company. | -$148.42M | -$136.00M | 10-Q filed 2026-08-03 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $35.69M | —Gross profit: unreported by this company. | -$64.59M | -$37.31M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $602,000 | —Gross profit: unreported by this company. | -$110.13M | -$85.94M | 10-Q filed 2025-11-10 |
- Assets
- $2.65B
- Equity
- $1.75B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $3.51M | -$664.57M | -$581.60M | -$345.93M |
| 2024-12-31 | $37.31M | -$466.57M | -$366.25M | -$144.68M |
| 2023-12-31 | $371.21M | -$222.54M | -$153.61M | -$269.85M |
| 2022-12-31 | $1.20M | -$673.16M | -$650.17M | -$532.93M |
| 2021-12-31 | $914.96M | $373.53M | $377.66M | $457.27M |
| 2020-12-31 | $719,000 | -$354.44M | -$348.87M | -$256.72M |
| 2019-12-31 | $289.59M | $46.74M | $66.86M | $49.99M |
| 2018-12-31 | $3.12M | -$158.94M | -$164.98M | -$99.01M |
| 2017-12-31 | $41.00M | -$64.65M | -$68.36M | -$77.91M |
| 2016-12-31 | $5.16M | -$68.13M | -$23.18M | -$55.88M |
Company filings
1 offering filing in 12 months · since Wed Oct 15
events
Results
ResultsAug 38-KExecutive or director change, Bylaws or fiscal year change, Shareholder vote results
Executive or director changeBylaws or fiscal year changeShareholder vote resultsJun 48-KResults
ResultsMay 48-KMaterial agreement, New debt, Unregistered share sale
Material agreementNew debtUnregistered share saleMar 168-KOther event
Other eventMar 118-KResults
ResultsFeb 128-K
5% owners ()
ORBIS INVESTMENT MANAGEMENT LTD
Stake update
BlackRock, Inc.
Stake update
ORBIS INVESTMENT MANAGEMENT LTD
Stake update
Capital World Investors
Passive stake
ARK Investment Management LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
KASINGER JAMES R.
General Counsel and Secretary
Sale$626,460Sep 24, 5:35 PM ET
Behbahani Ali
Director
Sale$780,935Sep 21, 6:40 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- ARK Investment Management
Period Tue 30 Jun 2026
3.4%Trimmed - Point72
Calls · Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Puts · Period Tue 30 Jun 2026
0.0%Same
News
Stories that named CRSP, and the market events around them.
Sign in to see thisBoard
The CRSP board could not be loaded.
Retry the CRSP boardnakagai
Signals on CRSP come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CRSP board